Gergen Mark J

Executive Chairman at PSTX; Executive VP, COO at Mirati Therapeutics, Inc.; SVP, Corporate Development at AMYLIN PHARMACEUTICALS INC

Sold, on record
$1.4M
Dollars the filings state
Form 4 sales
20
Latest Dec 10, 2024
Form 144 notices
1
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale AMYLIN PHARMACEUTICALS INCPlan not stated
    Oct 3, 2007 2007

    Sold 500 shares at $50.00 ($25k)

    Gergen Mark J, Sr VP, Corporate Development

    Sold 14.5% of holdings ($172k position)2,937 shares left1x usual sizeFiling

  2. 2 Form 4 sale AMYLIN PHARMACEUTICALS INCPlan not stated
    Nov 1, 2007 +29 days

    Sold 500 shares at $44.00 ($22k)

    Gergen Mark J, Sr VP, Corporate Development

    Sold 14.5% of holdings ($151k position)2,937 shares left1x usual sizeFiling

  3. 3 Form 4 sale AMYLIN PHARMACEUTICALS INCPlan not stated
    Feb 23, 2012 +1575 days

    Sold 7,518 shares at $17.03 ($128k)

    Gergen Mark J, SVP, Corporate Development

    Sold 12.1% of holdings ($1.1M position)54,826 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale AMYLIN PHARMACEUTICALS INCPlan not stated
    Mar 1, 2012 +7 days

    Sold 1,846 shares at $17.11 ($32k)

    Gergen Mark J, SVP, Corporate Development

    Sold 3.3% of holdings ($952k position)53,814 shares leftFiling

  5. 5 Form 4 sale Mirati Therapeutics, Inc.Unusual
    Jan 15, 2016 +1415 days

    Sold 10,000 shares at $25.92 ($259k)

    Gergen Mark J, Executive VP, COO

    Sold 63.5% of holdings ($408k position)5,748 shares leftFirst sale on recordFiling

  6. 6 Form 144 notice PSTXNotice
    Nov 26, 2024 +3238 days

    Filed to sell 120,000 shares ($343k)

    Gergen Mark J, Director, Officer

    10b5-1 planFirst sale on recordFiling

  7. 7 Form 4 sale PSTXRoutine
    Nov 26, 2024 same day

    Sold 30,000 shares at $9.27 ($278k)

    Gergen Mark J, Executive Chairman

    10b5-1 planSold 4.4% of holdings ($6.3M position)651,291 shares leftFirst sale on recordFollows a Form 144Filing

  8. 8 Form 4 sale PSTXRoutine
    Dec 10, 2024 +14 days

    Sold 30,000 shares at $9.46 ($284k)

    Gergen Mark J, Executive Chairman

    10b5-1 planSold 4.4% of holdings ($6.4M position)651,291 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (21)

Form 144 notices and Form 4 sales by Gergen Mark J
Source
Dec 10, 2024Dec 11, 2024PSTXExecutive ChairmanForm 4 sale30,000$284k4.4%RoutineSEC
Nov 26, 2024Nov 27, 2024PSTXExecutive ChairmanForm 4 sale30,000$278k4.4%RoutineSEC
Nov 26, 2024Nov 26, 2024PSTXDirector, OfficerForm 144 notice120,000$343kNoticeSEC
Jan 15, 2016Jan 19, 2016Mirati Therapeutics, Inc.Executive VP, COOForm 4 sale10,000$259k63.5%UnusualSEC
Mar 1, 2012Mar 2, 2012AMYLIN PHARMACEUTICALS INCSVP, Corporate DevelopmentForm 4 sale1,846$32k3.3%Plan not statedSEC
Feb 23, 2012Feb 24, 2012AMYLIN PHARMACEUTICALS INCSVP, Corporate DevelopmentForm 4 sale7,518$128k12.1%Plan not statedSEC
Nov 1, 2007Nov 2, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$22k14.5%Plan not statedSEC
Oct 3, 2007Oct 4, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$25k14.5%Plan not statedSEC
Oct 1, 2007Oct 2, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$25k14.5%Plan not statedSEC
Sep 4, 2007Sep 6, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale1,000$50k25.4%UnusualSEC
Aug 7, 2007Aug 8, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$25k14.5%Plan not statedSEC
Aug 1, 2007Aug 2, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$23k14.5%Plan not statedSEC
Jul 24, 2007Jul 25, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$23k14.5%Plan not statedSEC
Jul 2, 2007Jul 3, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$21k14.5%Plan not statedSEC
Jun 1, 2007Jun 4, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale1,000$46k25.4%UnusualSEC
May 21, 2007May 23, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$23k14.5%Plan not statedSEC
May 1, 2007May 2, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$21k14.5%Plan not statedSEC
Apr 2, 2007Apr 3, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$19k14.5%Plan not statedSEC
Mar 1, 2007Mar 2, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$19k14.5%Plan not statedSEC
Feb 1, 2007Feb 2, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$19k16.1%Plan not statedSEC
Jan 3, 2007Jan 4, 2007AMYLIN PHARMACEUTICALS INCSr VP, Corporate DevelopmentForm 4 sale500$18k18.6%Plan not statedSEC